Cookies

Like most websites The Analytical Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Pharma & Biopharma

Fields & Applications COVID-19

Better Methods for Better Vaccines

| Ewoud van Tricht

Ewoud van Tricht explores three novel methods that could streamline the development of adenovirus vaccines for COVID-19 at Janssen

Techniques & Tools Mass Spectrometry

A Passion for Discovery

| Mike Thurman, Imma Ferrer

Mike Thurman and Imma Ferrer share their passion for "discovery research" and how it has often led them to unprecedented findings...

Fields & Applications Pharma & Biopharma

Copycat Chemistry: Uncovering Counterfeit Drugs

| Ravi Kalyanaraman, Scott Huffman

As fraudsters get more sophisticated, it’s vital that counterfeit analysis keeps pace

Techniques & Tools Mass Spectrometry

Taking MALDI to the Next Level

| Shannon Cornett

Is the next age in MALDI imaging upon us?

Fields & Applications Pharma & Biopharma

Safety Guaranteed

Nadine Ritter, President of Global Biotech Experts, talks us through her illustrious career in pharmaceutical analysis

Techniques & Tools Spectroscopy

Fast and Furious HOS Analysis?

| Jeff Zonderman

Could microfluidic modulation spectroscopy improve higher order structure analysis across the pharma industry?

Fields & Applications Pharma & Biopharma

(Prote)omics in Next-Gen Drug Development

| Mark Rogers

Omics fields will play a key role in the quest for personalized medicine

Fields & Applications Pharma & Biopharma

The Future of Nucleic Acid Therapies

| Brian Carothers

Brian Carothers discusses the growth of nucleic acid therapies - and the analytical community's role in their success

Fields & Applications Pharma & Biopharma

Daddy, What's the Big Deal with Antibodies?

| Koen Sandra

Koen Sandra ushers in our (bio)pharma theme for the latter half of 2020

Fields & Applications COVID-19

Small, But Mighty

| Brent R Stockwell

Small-molecule inhibition of the SARS-CoV-2 viral protease may represent a promising route for therapy


Sister Publications

You might be interested in our Sister Publications:

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register